Alethea Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-2,843
| Closed | -$488K | – | 31 |
|
2024
Q2 | $488K | Buy |
+2,843
| New | +$488K | 0.37% | 13 |
|
2023
Q4 | – | Sell |
-3,470
| Closed | -$517K | – | 36 |
|
2023
Q3 | $517K | Buy |
+3,470
| New | +$517K | 0.64% | 7 |
|
2023
Q2 | – | Sell |
-3,990
| Closed | -$636K | – | 53 |
|
2023
Q1 | $636K | Buy |
+3,990
| New | +$636K | 0.67% | 16 |
|
2021
Q4 | – | Sell |
-8,270
| Closed | -$892K | – | 70 |
|
2021
Q3 | $892K | Buy |
8,270
+2,101
| +34% | +$227K | 0.79% | 11 |
|
2021
Q2 | $695K | Buy |
+6,169
| New | +$695K | 0.44% | 26 |
|
2021
Q1 | – | Sell |
-12,338
| Closed | -$1.32M | – | 76 |
|
2020
Q4 | $1.32M | Buy |
+12,338
| New | +$1.32M | 0.66% | 16 |
|
2020
Q3 | – | Sell |
-9,311
| Closed | -$914K | – | 66 |
|
2020
Q2 | $914K | Sell |
9,311
-429
| -4% | -$42.1K | 0.53% | 15 |
|
2020
Q1 | $742K | Buy |
+9,740
| New | +$742K | 0.48% | 19 |
|
2019
Q3 | – | Sell |
-4,707
| Closed | -$342K | – | 81 |
|
2019
Q2 | $342K | Buy |
+4,707
| New | +$342K | 0.22% | 67 |
|
2018
Q3 | – | Sell |
-5,085
| Closed | -$471K | – | 73 |
|
2018
Q2 | $471K | Sell |
5,085
-6,914
| -58% | -$640K | 0.8% | 39 |
|
2018
Q1 | $1.14M | Buy |
11,999
+3,999
| +50% | +$379K | 1.54% | 16 |
|
2017
Q4 | $774K | Hold |
8,000
| – | – | 1.23% | 23 |
|
2017
Q3 | $711K | Hold |
8,000
| – | – | 0.83% | 34 |
|
2017
Q2 | $580K | Buy |
+8,000
| New | +$580K | 0.66% | 46 |
|
2016
Q1 | – | Sell |
-42,583
| Closed | -$2.52M | – | 60 |
|
2015
Q4 | $2.52M | Buy |
+42,583
| New | +$2.52M | 2.92% | 5 |
|